Editas Medicine Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:EDIT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
03 Dec 25	SellUS$993	Amy Parison	Individual	461	US$2.15
03 Dec 25	SellUS$12,064	Gilmore O’Neill	Individual	5,603	US$2.15
03 Dec 25	SellUS$1,535	Linda Burkly	Individual	713	US$2.15
03 Sep 25	SellUS$1,189	Amy Parison	Individual	458	US$2.60
03 Sep 25	SellUS$14,517	Gilmore O’Neill	Individual	5,592	US$2.60
03 Sep 25	SellUS$1,843	Linda Burkly	Individual	710	US$2.60
07 Aug 25	SellUS$1,752	Amy Parison	Individual	679	US$2.58
31 Jul 25	SellUS$12,757	Linda Burkly	Individual	5,121	US$2.49
03 Jun 25	SellUS$26,196	Gilmore O’Neill	Individual	15,192	US$1.72
03 Jun 25	SellUS$1,252	Linda Burkly	Individual	726	US$1.72
03 Jun 25	SellUS$769	Amy Parison	Individual	446	US$1.72
04 Mar 25	SellUS$4,946	Linda Burkly	Individual	2,891	US$1.71
04 Mar 25	SellUS$28,452	Gilmore O’Neill	Individual	16,632	US$1.71
04 Mar 25	SellUS$7,030	Erick Lucera	Individual	4,109	US$1.71

Insider Trading Volume

Insider Buying: EDIT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of EDIT?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	354,503	0.363%
Institutions	43,952,162	45%
General Public	53,311,995	54.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.3%.

Top Shareholders

Top 25 shareholders own 37.2% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.22%	BlackRock, Inc.	8,019,891	US$16.4m	17.6%	no data
7.14%	The Vanguard Group, Inc.	6,965,618	US$14.3m	-2.71%	no data
2.09%	Geode Capital Management, LLC	2,040,166	US$4.2m	3.86%	no data
2.03%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	1,980,961	US$4.1m	112%	no data
1.97%	State Street Global Advisors, Inc.	1,925,044	US$3.9m	4.23%	no data
1.62%	Two Sigma Investments, LP	1,584,155	US$3.2m	63.3%	0.01%
1.31%	Renaissance Technologies LLC	1,277,400	US$2.6m	43.8%	no data
1.23%	Two Sigma Advisers, LP	1,205,000	US$2.5m	28.1%	no data
1.13%	Susquehanna International Group, LLP	1,107,544	US$2.3m	17.3%	no data
1.06%	Morgan Stanley	1,030,486	US$2.1m	-24.8%	no data
1.04%	Bank of America Corporation	1,013,673	US$2.1m	-5.25%	no data
0.95%	Dimensional Fund Advisors LP	931,910	US$1.9m	-33.7%	no data
0.82%	Jacobs Levy Equity Management Inc	800,023	US$1.6m	762%	0.01%
0.8%	Charles Schwab Investment Management, Inc.	779,955	US$1.6m	11.2%	no data
0.69%	Northern Trust Global Investments	669,689	US$1.4m	1.41%	no data
0.68%	AQR Capital Management, LLC	667,047	US$1.4m	-10.7%	no data
0.67%	JP Morgan Asset Management	650,162	US$1.3m	-1.51%	no data
0.59%	Stifel Asset Management Corp.	580,285	US$1.2m	4.51%	no data
0.58%	Kennedy Capital Management LLC	565,641	US$1.2m	-0.35%	0.02%
0.53%	Jane Street Group, LLC	516,595	US$1.1m	97.6%	no data
0.48%	J. Lamarck SIM S.p.A.	472,200	US$968.0k	0%	0.98%
0.43%	UBS Asset Management AG	422,394	US$865.9k	-33%	no data
0.4%	Walleye Capital LLC	393,830	US$807.4k	0%	no data
0.37%	Citadel Advisors LLC	362,193	US$742.5k	-43.3%	no data
0.37%	Acadian Asset Management LLC	356,658	US$731.2k	-9.05%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/04 13:14
End of Day Share Price	2026/01/02 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Editas Medicine, Inc. is covered by 26 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Joel Beatty	Baird
Jack Allen	Baird
Huidong Wang	Barclays